Deals ramp up in Asia's healthcare space with cancer focus :

An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.

Related Keywords

China , Lugano , Ticino , Switzerland , Singapore , Nanjing , Jiangsu , Hong Kong , Sweden , Shenzhen , Guangdong , Macau , Japan , Jilin , United Kingdom , Miami , Florida , United States , Chinese , Suno Biologics , Garri Zmudze , Sunho Biologics , Pureos Bioventures , Asia Pacific , John Lee , World Health Organisation , Hong Kong Integrated Oncology Center , Technology Innovation Zone , Singapore Economic Development Board , Hong Kong Stock Exchange , Astrazeneca , Haymarket Media , Asia Summit On Global Health , Frontier Group , United Kingdom Swedish , New Frontier Group , Economic Development Board , Nanjing City Based , Greater Bay Area , Special Adminstrative Regions , Guangzhou United Familty Hospital , New Frontier Shenzhen United Family , New Frontier Greater Bay Area , Asia Summit , Global Health , Hong Kong Shenzhenit Park , Shenzhen Hong Kong Science , Technology Innovation Co Operation ,